Literature DB >> 20336324

Favorable outcome in a case of Mycoplasma pneumoniae-associated crescentic glomerulonephritis.

Anne-Laure Adra1, Marie-Gabrielle Vigue, Fabienne Dalla Vale, Lydia Ichay, Pierre Raynaud, Aude Mariani, Denis Morin.   

Abstract

Mycoplasma pneumoniae-associated nephritis has been reported in children with various pathological findings. It nevertheless remains an uncommon disease and, within this clinical context, endo-and extracapillary glomerulonephritis in a child has never been described. We report here a case of a 3-year-old girl diagnosed with severe crescentic glomerulonephritis associated with M. pneumoniae infection who presented with nephrotic syndrome and impaired renal function. The serum C3 complement level was initially low but returned to normal after 1 month. Two courses of three methylprednisolone pulses were administered in association with plasmapheresis and, secondarily, mycophenolate mophetil. This treatment regimen led to disease remission and a favorable renal outcome at the 6-month follow-up. However, the treatment guidelines in this situation remain debatable.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336324     DOI: 10.1007/s00467-010-1491-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Mycoplasma pneumoniae-associated Henoch-Schönlein purpura nephritis.

Authors:  K Kaneko; S Fujinaga; Y Ohtomo; R Nagaoka; K Obinata; Y Yamashiro
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

2.  Acute IgA nephropathy associated with mycoplasma pneumoniae infection.

Authors:  Koichi Suzuki; Koji Hirano; Norio Onodera; Toru Takahashi; Hiroshi Tanaka
Journal:  Pediatr Int       Date:  2005-10       Impact factor: 1.524

3.  Mycoplasma pneumoniae detection with PCR in renal tissue of a patient with acute glomerulonephritis.

Authors:  María del Carmen Laso; María Estela Cadario; Laura Haymes; Irene Grimoldi; Ziomara Balbarrey; Enrique Casanueva
Journal:  Pediatr Nephrol       Date:  2006-07-04       Impact factor: 3.714

Review 4.  Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet.

Authors:  B Rodríguez-Iturbe; S Batsford
Journal:  Kidney Int       Date:  2007-03-07       Impact factor: 10.612

Review 5.  C3 nephritic factor and mesangiocapillary glomerulonephritis.

Authors:  D G Williams
Journal:  Pediatr Nephrol       Date:  1997-02       Impact factor: 3.714

6.  Mycoplasma pneumoniae-associated nephritis in children.

Authors:  M H Saïd; M P Layani; S Colon; G Faraj; C Glastre; P Cochat
Journal:  Pediatr Nephrol       Date:  1999-01       Impact factor: 3.714

7.  Crescentic glomerulonephritis in children.

Authors:  H M Jardim; J Leake; R A Risdon; T M Barratt; M J Dillon
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

8.  Outcome of severe acute post-streptococcal glomerulonephritis in New Zealand children.

Authors:  William Wong; Maxwell Clarke Morris; Jonathan Zwi
Journal:  Pediatr Nephrol       Date:  2008-12-19       Impact factor: 3.714

9.  Rapid diagnosis of Mycoplasma pneumoniae infection in children by polymerase chain reaction.

Authors:  Fang-Ching Liu; Po-Yen Chen; Fang- Liang Huang; Chi-Ren Tsai; Chun-Yi Lee; Li-Chung Wang
Journal:  J Microbiol Immunol Infect       Date:  2007-12       Impact factor: 4.399

Review 10.  Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.

Authors:  Christoph Licht; Veronique Fremeaux-Bacchi
Journal:  Thromb Haemost       Date:  2009-02       Impact factor: 5.249

View more
  2 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection.

Authors:  Astrid Godron; Sabine Pereyre; Catherine Monet; Brigitte Llanas; Jérôme Harambat
Journal:  Pediatr Nephrol       Date:  2013-06-26       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.